Skip to content
OpenCapital
Get started

Zentalis Pharmaceuticals, Inc. ZNTL Q1 2026 earnings

Reported May 12, 2026 · Before market open

EPS-$0.50Miss by $0.01
EPS estimate-$0.49

Next report

Aug 5, 2026 (In 1 week)
EPS estimate-$0.45

Versus estimates

Revenue

Q4 2024$26.9M

Diluted EPS

Q1 2026-$0.50Miss by $0.01
Q4 2025-$0.49Miss by $0.08Q3 2025-$0.37Beat by $0.12Q2 2025-$0.37Beat by $0.19Q1 2025-$0.67In lineQ4 2024-$0.66Beat by $0.09

Ask the moment Zentalis Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Zentalis Pharmaceuticals, Inc. report Q1 2026 earnings?
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Q1 2026 earnings on May 12, 2026 before market open.
What were Zentalis Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
Zentalis Pharmaceuticals, Inc. reported eps of $-0.50 for Q1 2026.
Did Zentalis Pharmaceuticals, Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.49 by $0.01.
How did Zentalis Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 25.4% from $-0.67.
Where can I find Zentalis Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001725160-26-000041) and the 10-Q periodic report (0001725160-26-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.